Latin America Microbial Identification Market

Latin America Microbial Identification Market Size (2024 to 2029)

As per the research report, the size of the Latin America Microbial Identification Market size is calculated to approach USD 0.34 billion by 2027 with a CAGR of 5.90%, from the 2022 valuation of USD 0.25 billion during the forecast period 2024 to 2029.

Microbial identification entails the identification of various kinds of microorganisms that are prone to cause different infectious conditions in humans. In the present world, the major types of microorganisms that cause diseases are parasites, bacteria, fungi and viruses. Their presence contaminates the manufacturing facilities, raw materials and food products.

The growing occurrence of several infections caused by microorganisms is the key driver for the growth of the market. Besides, the increasing consciousness about food safety, coupled with strict regulations and guidelines by the government to ensure the cleanliness of surroundings in industries acts as a serious promoter for the market growth in future.

This research report on the Latin America Microbial Identification Market has been segmented and sub-segmented into the following categories.

By Method

• Genotypic
• Proteomics-based
• Phenotypic

By Application

• F&B
• Diagnostic
• Pharmaceutical
• Environmental

By Product

• Identification Services
• Consumables
• Instruments

By End User

• Food Manufacturing Industries
• Pharmaceutical Companies
• Hospitals
• Diagnostic Centres
• Others

By Country

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

The Hospitals and Diagnostic Centres segment led the Latin America market in 2023, owing to the high incidence of various microbial infections.

The emerging nations in the region are progressively concentrating on bettering the facilities to identify the presence of microbes in the environment. This is scripted to promote the growth of the market in the region.

Prominent companies leading in the Latin America Microbial Identification Market profiled in the report are Shimadzu Corporation, Dickinson & Company, Biolog Inc., Merck KGaA, IEH Laboratories & Consulting Group, Trivitron Healthcare, Thermo Fisher Scientific Inc., Bruker Corporation, VWR Corporation and Charles River Laboratories International Inc.